Barbara Fischer1, Carey Gleason2, Sanjay Asthana2. 1. Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Affairs Hospital, Madison, Wisconsin. Electronic address: barbara.fischer@va.gov. 2. Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Affairs Hospital, Madison, Wisconsin; Wisconsin Alzheimer's Disease Research Center (ADRC), Madison, Wisconsin; Division of Geriatrics and Gerontology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
Abstract
OBJECTIVE: Results of the Women's Health Initiative (WHI) and Women's Health Initiative Memory Study (WHIMS) suggested that hormone therapy (HT) may be detrimental to cognitive health. This article reviews clinical studies that address issues relevant to those results. DESIGN: Literature review. INTERVENTION(S): A search of Pubmed and Web of Science was conducted using the search terms HT and cognition, HT and mood. Clinical and observational studies were selected if they were published after the year 2000. Theories of HT mechanisms of action, pharmacology, biology, and observational and clinical trials are discussed. RESULT(S): Although observational and clinical trials show conflicting findings, methodologic considerations must be acknowledged. HT formulation and dose, route of administration, timing of initiation, length of treatment, and health of participants all contribute to inconsistencies in results. Transdermal estradiol and micronized progesterone administered at time of menopause are generally associated with cognitive and affective benefit. CONCLUSION(S): At the present time, results from existing studies are equivocal regarding the benefits of HT on cognition and affect. Future studies, such as the Kronos Early Estrogen Prevention Study (KEEPS), should address methodologic inconsistencies to provide clearer answers to this important question. Published by Elsevier Inc.
OBJECTIVE: Results of the Women's Health Initiative (WHI) and Women's Health Initiative Memory Study (WHIMS) suggested that hormone therapy (HT) may be detrimental to cognitive health. This article reviews clinical studies that address issues relevant to those results. DESIGN: Literature review. INTERVENTION(S): A search of Pubmed and Web of Science was conducted using the search terms HT and cognition, HT and mood. Clinical and observational studies were selected if they were published after the year 2000. Theories of HT mechanisms of action, pharmacology, biology, and observational and clinical trials are discussed. RESULT(S): Although observational and clinical trials show conflicting findings, methodologic considerations must be acknowledged. HT formulation and dose, route of administration, timing of initiation, length of treatment, and health of participants all contribute to inconsistencies in results. Transdermal estradiol and micronized progesterone administered at time of menopause are generally associated with cognitive and affective benefit. CONCLUSION(S): At the present time, results from existing studies are equivocal regarding the benefits of HT on cognition and affect. Future studies, such as the Kronos Early Estrogen Prevention Study (KEEPS), should address methodologic inconsistencies to provide clearer answers to this important question. Published by Elsevier Inc.
Authors: Susan G Kornstein; Marisa Toups; A John Rush; Stephen R Wisniewski; Michael E Thase; James Luther; Diane Warden; Maurizio Fava; Madhukar H Trivedi Journal: J Womens Health (Larchmt) Date: 2013-02 Impact factor: 2.681
Authors: Sarah E Mennenga; Stephanie V Koebele; Abeer A Mousa; Tanya J Alderete; Candy W S Tsang; Jazmin I Acosta; Bryan W Camp; Laurence M Demers; Heather A Bimonte-Nelson Journal: Steroids Date: 2014-08-23 Impact factor: 2.668
Authors: Richard L Doty; Isabelle Tourbier; Victoria Ng; Jessica Neff; Deborah Armstrong; Michelle Battistini; Mary D Sammel; David Gettes; Dwight L Evans; Natasha Mirza; Paul J Moberg; Tim Connolly; Steven J Sondheimer Journal: Neurobiol Aging Date: 2015-03-10 Impact factor: 4.673
Authors: Steven G Kohama; Lauren Renner; Noelle Landauer; Alison R Weiss; Henryk F Urbanski; Byung Park; Mary Lou Voytko; Martha Neuringer Journal: J Neurosci Date: 2016-10-05 Impact factor: 6.167
Authors: Johanna Seitz; Marek Kubicki; Emily G Jacobs; Sara Cherkerzian; Blair K Weiss; George Papadimitriou; Palig Mouradian; Stephen Buka; Jill M Goldstein; Nikos Makris Journal: Hum Brain Mapp Date: 2018-12-12 Impact factor: 5.038
Authors: Alison Berent-Spillson; Emily Briceno; Alana Pinsky; Angela Simmen; Carol C Persad; Jon-Kar Zubieta; Yolanda R Smith Journal: Psychoneuroendocrinology Date: 2015-05-14 Impact factor: 4.905
Authors: Keiko Kurita; Victor W Henderson; Margaret Gatz; Jan St John; Howard N Hodis; Roksana Karim; Wendy J Mack Journal: Fertil Steril Date: 2016-05-14 Impact factor: 7.329
Authors: Alison Berent-Spillson; Angela S Kelley; Carol C Persad; Tiffany Love; Kirk A Frey; Nancy E Reame; Robert Koeppe; Jon-Kar Zubieta; Yolanda R Smith Journal: Menopause Date: 2018-12 Impact factor: 2.953